Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...

Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 5 years ago, it would be worth $2,432.39 today based on a ...

Corporation's stock has reached a new 52-week high, with shares climbing to $282.87. This milestone reflects a significant uptrend for the medical device company, known for its innovative insulin pump ...

In a report released today, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Intuitive Surgical (ISRG – Research Report), with a ...

UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00. Trading at $263.69 and with a market capitalization of $10.12 billion, the ...

SBI Capital Markets and HDFC Bank were the book running lead managers of the Capital Infra Trust Invit, while Kfin Technologies served as the registrar for the issue. Disclaimer: Business Today ...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2024 ANNEXE B Form to be used for the disclosure of the total number of ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $105.00. The company’s shares ...

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information ...